Champions Oncology, Inc. Common Stock (NASDAQ: CSBR) last traded at $4.84, down 2.81% on the session. The quote above updates while this page is open; the figures below are drawn from Champions Oncology, Inc. Common Stock’s own filings and are restated only when a new one is published.
Champions Oncology, Inc. Common Stock trades on NASDAQ under the ticker CSBR. Its market capitalisation is $67.37 million.
Valuation measures for Champions Oncology, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $67.37M |
|---|---|
| Enterprise value | $91.84M |
| Price / sales | 1.11 |
| Price / book | 17.30 |
| Beta | 0.32 |
Trailing-twelve-month figures tagged in Champions Oncology, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $60.66M |
|---|---|
| Net income (TTM) | -$1.14M |
| EPS (TTM) | -$0.0800 |
| Gross margin | 49.82% |
| Operating margin | -1.68% |
| Return on equity | -29.15% |
| Cash | $4.36M |
Range and volume for CSBR over the past 52 weeks.
| 52-week high | $8.31 |
|---|---|
| 52-week low | $4.59 |
| Volume | 1.9K |
| Average volume | 11.2K |
| Previous close | $4.98 |
Invest a chosen dollar amount in Champions Oncology, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CSBR.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.